Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-99-003773
Filing Date
1999-03-31
Accepted
1999-03-31 00:00:00
Documents
7
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 THERAPEUTIC ANTIBODIES INC 10-K 241375
2 EMPLOYMENT AGREEMENT EX-10.24 17673
3 LETTER AGREEMENT EX-10.25 6610
4 CONSULTANCY AGREEMENT EX-10.26 35423
5 CONSULTANCY AGREEMENT EX-10.27 10775
6 LIST OF SUBSIDIARIES EX-21.1 834
7 FINANCIAL DATA SCHEDULE EX-27.1 2057
  Complete submission text file 0000950144-99-003773.txt   316809
Mailing Address 1207 17TH AVENUE SOUTH STE 103 NASHVILLE TN 37212
Business Address 1207 17TH AVENUE SOUTH STE 103 NASHVILLE TN 37212 6153271027
THERAPEUTIC ANTIBODIES INC /DE (Filer) CIK: 0000944744 (see all company filings)

EIN.: 621212485 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25978 | Film No.: 99582027
SIC: 8071 Services-Medical Laboratories